Pages

AstraZeneca Press release

Go to the AstraZeneca International website
MARTIN MACKAY TO LEAD ASTRAZENECA’S RESEARCH AND DEVELOPMENT ORGANISATION
AstraZeneca today announced the appointment of Martin Mackay to the newly-created position of President of R&D. Martin will lead the company’s research and development organisation and will have overall accountability for delivering new products – small molecules and biologics – from AstraZeneca’s pipeline. He will start his new role on 1 July 2010 and will be based at the company’s headquarters in London.
View full press release
This email has been sent via AstraZeneca's email alert service. Update your email preferences, unsubscribe from this service or contact us.
Legal notice Privacy policy © 2010 AstraZeneca

No comments:

Post a Comment